Franks et al. looked at how the drug affected newborn babies, the severity of their deformities, and reviewed the drug in its early years. Webb in 1963 also reviewed the history of the drug and the different forms of birth defects it had caused. "The most common form of birth defects from thalidomide is shortened limbs, with the ...
Rangel v. Sanofi Aventis U.S., LLC et al, No. 6:2010cv01359 - Document 39 (D. Kan. 2012) case opinion from the District of Kansas US Federal District Court.
Oct 11, 2016 ... CASTRO, M.D., P.A. v. SANOFI PASTEUR INC., No. 2:2011cv07178 - Document 475 (D.N.J. 2016) case opinion from the District of New Jersey US Federal District Court.
... Deepika Kandula,; Renee Shah,; Jimee Hwang,; Justin M. Cohen,; Roly Gosling and; Luke Rooney. †Contributed equally. Malaria Journal201514:204. https://doi.org/10.1186/s12936-015-0714-3. © Chen et al.; licensee BioMed Central. 2015. Received: 4 February 2015. Accepted: 23 April 2015. Published: 15 May 2015 ...
Feb 2, 2018 ... All vaccines routinely recommended for children 6 years of age and younger in the U.S. are available in formulations that do not contain thimerosal. ... in 1999, this review found no evidence of harm from the use of thimerosal as a vaccine preservative, other than local hypersensitivity reactions (Ball et al.
All the patients in the study had not received previous pharmacologic treatment for type 2 diabetes that had been recently diagnosed (i.e., within 3 years). ..... Dr. Herman reports receiving consulting fees from Amylin, Eli Lilly, GlaxoSmithKline, Merck, and Wyeth and consulting fees and grant support from Sanofi-Aventis.
Download abstracts from booth posters and sessions presented by investigators at meetings going back to 2003.
patients with ischemic stroke in the United States.5 A variety of strategies may be ... emergency medical services and several organizational fea- tures of Primary ..... 4. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue. Albers et al .
Nov 8, 2017 ... For example, in 2012–2013 Janssen donated $1.5 million, and in 2011–2012 contributors included Merck ($915,149), Genzyme ($762,000), Sanofi-Aventis ($ 600,000), and Abbott Laboratories ($550,000) (Lenzer 2015; Smith et al. 2012). This significant financial relationship further amplifies the potential ...